We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vaso Corporation (QX) | USOTC:VASO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0023 | 1.73% | 0.135 | 0.131 | 0.147 | 0.1368 | 0.131 | 0.1368 | 21,600 | 21:00:16 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 23, 2024
VASO CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware | 000-18105 | 11-2871434 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
137 Commercial St., Suite 200, Plainview, New York 11803
(Address of Principal Executive Offices and Zip Code)
(516) 997-4600
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | ||
Common Stock | Vaso | OTCQX |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☒ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☒ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Exchange Act (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
On August 7, 2024, Vaso Corporation (“Vaso”) filed a Definitive Proxy Statement on Schedule 14A covering, among other topics, a proposed business combination (the “Business Combination”) as described therein involving Vaso, Achari Ventures Holdings Corp. I (“Achari”) and Achari Merger Sub, Inc. On August 14, 2024, Achari filed its periodic report on Form 10-Q containing its unaudited financial statements for the three and six months ended June 30, 2024. On August 14, 2024, Vaso filed its periodic report on Form 10-Q containing its unaudited financial statements for the three and six months ended June 30, 2024.
Included in this Current Report on Form 8-K as Exhibit 99.1 are unaudited pro forma condensed financial information for the six months ended June 30, 2024 and the year ended December 31, 2023, assuming the completion of the Business Combination and the related transactions as if they had occurred on January 1, 2023.
The pro forma financial information included in this Current Report on Form 8-K has been presented for informational purposes only. It does not purport to represent the actual results of operations that Vaso and Achari would have achieved had the companies been combined during the periods presented in the pro forma financial information and is not intended to project the future results of operations that the combined company may achieve after the Business Combination.
Item 9.01. Financial Statements and Exhibits.
The following exhibits are provided as part of this Current Report on Form 8-K:
(d) Exhibits:
Exhibit No. | Description | |
99.1 | Unaudited pro forma condensed combined financial information | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 23, 2024
VASO CORPORATION | ||
By: | /s/ Jun Ma | |
Name: | Jun Ma | |
Title: | Chief Executive Officer and President |
2
Exhibit 99.1
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
The following unaudited pro forma condensed combined financial data presents the combination of the financial information of Achari and Vaso adjusted to give effect to the Business Combination and related transactions and is provided to aid you in your analysis of the financial aspects of the Business Combination, which is referred to as the “Transactions.”
The unaudited pro forma condensed combined financial statements are based on the Achari historical financial statements and Vaso historical financial statements as adjusted to give effect to the Transactions. The unaudited pro forma condensed combined balance sheet gives pro forma effect to the Transactions as if they had been consummated on June 30, 2024 (except for the redemptions which took place in connection with the Special Meeting, as discussed below). The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2024 and for the year ended December 31, 2023 gives effect to the Transactions as if they had occurred on January 1, 2023, the beginning of the earliest period presented.
The unaudited pro forma condensed combined financial statements were prepared in accordance with Article 11 of SEC Regulation S-X. The adjustments presented in the unaudited pro forma condensed combined financial statements have been identified and presented to provide relevant information necessary for an understanding of the combined company reflecting the Transactions.
The unaudited pro forma condensed combined financial statements are provided for illustrative purposes only and are not necessarily indicative of what the actual results of operations and financial position would have been had the Transactions taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of the combined company. Achari and Vaso entered into a working capital agreement prior to the Business Combination. Accordingly, a pro forma adjustment was required to eliminate this activity between the companies.
The unaudited pro forma condensed combined balance sheet as of June 30, 2024 has been prepared using, and should be read in conjunction with, the following:
● | Achari’s unaudited balance sheet as of June 30, 2024 and the related notes included in Achari’s current report on Form 10-Q filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 13, 2024 (the “Achari June 30 10-Q”); and |
● | Vaso’s unaudited condensed consolidated balance sheet as of June 30, 2024 and the related notes included current report on Form 10-Q filed with the SEC on August 14, 2024 (the “Vaso June 30 10-Q”). |
The unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2024 has been prepared using, and should be read in conjunction with, the following:
● | Achari’s unaudited statement of operations for the six months ended June 30, 2024 and the related notes included in the Achari June 30 10-Q; and |
● | Vaso’s unaudited condensed consolidated statement of operations for the six months ended June 30, 2024 and the related notes included in the Vaso June 30 10-Q. |
The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2023 has been prepared using, and should be read in conjunction with, the following:
● | Achari’s audited statement of operations for the year ended December 31, 2023 and the related notes included in the joint proxy statement/prospectus filed on Form 424 with the SEC on August 8, 2024 (the “Proxy Statement/Prospectus”); and |
● | Vaso’s audited consolidated statement of operations for the year ended December 31, 2023 and the related notes included in the Proxy Statement/Prospectus. |
Such unaudited pro forma financial information has been prepared on a basis consistent with the financial statements of Vaso. This information should be read together with Achari’s and Vaso’s financial statements and related notes thereto, the sections titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Achari,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Vaso” and other financial information included in the Proxy Statement/Prospectus, including the Business Combination Agreement and the descriptions of certain items thereof set forth in the Proxy Statement/Prospectus.
Although the unaudited pro forma combined financial information is presented on the assumption that the Reverse Stock Split described in the section entitled “Proposal 4: The Reverse Stock Split Proposal” does not occur, the effect of the Reverse Stock Split on pro forma earnings per share is disclosed in Note 4 of “Notes to Unaudited Pro Form Condensed Combined Financial Information” below. Achari and Vaso have made this assumption as they each deem the likelihood of a Reverse Stock Split as uncertain. For further information with respect to the assumption as to why a Reverse Stock Split does not occur, see the section entitled “Share Calculations and Ownership Percentages” in the Proxy Statement/Prospectus. As set out in such section entitled “Share Calculations and Ownership Percentages”, the Reverse Stock Split will not be necessary if the trading price exceeds $4.00 (taking into account the exchange ratio as set out in the Business Combination Agreement). The Reverse Stock Split will be necessary if the current trading price of the Vaso Common Stock does not increase prior to the Business Combination. Achari and Vaso believe that the trading price of Vaso’s common stock on the over-the-counter market does not currently reflect either the value to Vaso of consummating the Business Combination or the value of Vaso’s business itself. This belief may be misplaced. Neither Achari nor Vaso can guarantee that the market price of Vaso’s common stock will increase prior to the Business Combination or that the value of the Class A Common Stock after the Business Combination will increase or maintain its initial market price.
Description of the Business Combination
On December 6, 2023, Achari, Merger Sub, and Vaso entered into the Business Combination Agreement, pursuant to which the Merger Sub will merge with and into Vaso, with Vaso surviving as a wholly-owned subsidiary of Achari (the “Merger”) and Achari will change its name to Vaso Holding Corp which will continue as the surviving public corporation after the Closing (collectively, the “Business Combination”).
2
Redemption of shares
On December 18, 2023, Achari held a Special Meeting, at which its shareholders voted to extend the date by which Achari must complete a business combination from January 19, 2024 to July 19, 2024. Holders of common shares had the right to have Achari redeem their shares for cash in an amount equal to the pro-rata portion of cash and investments in the Trust Account, which had a balance of approximately $7.0 million as of the date of the Special Meeting. Stockholders holding 87,380 shares of common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $1.0 million (approximately $10.89 per share) was utilized from the Trust Account to pay such redeeming shareholders.
On July 16, 2024, Achari held a special meeting (the “July 2024 Special Meeting”), at which its shareholders voted to extend the date by which Achari must complete a business combination from July 19, 2024 to October 19, 2024. Holders of common shares had the right to have Achari redeem their shares for cash in an amount equal to the pro-rata portion of cash and investments in the Trust Account, which had a balance of approximately $6.3 million as of the date of the Special Meeting. Stockholders holding 241,931 shares of common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $2.8 million (approximately $11.48 per share) was utilized from the Trust Account to pay such redeeming shareholders following the July 2024 Special Meeting.
Accounting for the Business Combination
The Business Combination is expected to be accounted for as a “reverse recapitalization” in accordance with U.S. GAAP. Under this method of accounting, Achari will be treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination will be treated as the equivalent of Vaso issuing stock for the net assets of Achari, accompanied by a recapitalization. The net assets of Achari will be stated at historical cost, with no goodwill or other intangible assets recorded. There will be no accounting effect or change in the carrying amount of the assets and liabilities as a result of the recapitalization.
This determination is primarily based on the fact that subsequent to the Business Combination, Vaso’s stockholders are expected to have a majority of the voting power of the Combined Company, Vaso will comprise all of the ongoing operations of the Combined Company, Vaso directors will be the governing body of the Combined Company, and Vaso’s senior management will comprise all of the senior management of the Combined Company. Accordingly, for accounting purposes, the Business Combination will be treated as the equivalent of Vaso issuing shares for the net assets of Achari, accompanied by a recapitalization. The net assets of Achari will be stated at historical costs. No goodwill or other intangible assets will be recorded. Operations prior to the Business Combination will be those of Vaso.
Basis of Pro Forma Presentation
Although the unaudited pro forma combined financial information is presented on the assumption that the Reverse Stock Split described in the section entitled “Proposal 4: The Reverse Stock Split Proposal” in the Proxy Statement/Prospectus does not occur, the effect of the Reverse Stock Split on pro forma earnings per share is disclosed in Note 4 of “Notes to Unaudited Pro Form Condensed Combined Financial Information” below. Achari and Vaso have made this assumption as they each deem the likelihood of a Reverse Stock Split as uncertain. For further information with respect to the assumption as to why a Reverse Stock Split does not occur, see the section entitled “Share Calculations and Ownership Percentages” in the Proxy Statement/Prospectus.
3
The unaudited pro forma combined financial information included herein has been prepared using the assumptions below with respect to the potential redemption into cash of Achari Common Stock:
● | Assuming No Redemptions (Scenario 1): This presentation assumes that no Public Stockholders exercise their right to redeem their Public Shares (excluding the Redeemed Public Shares) for their pro rata share of the Trust Account, and thus, the full amount held in the Trust Account as of the Closing is available for the Business Combination; and |
● | Assuming Maximum Redemptions (Scenario 2): This presentation assumes that a maximum of 309,010 Public Shares issued and outstanding as of the Closing are redeemed at a redemption price of $11.51 per share as of June 30, 2024. |
The following table illustrates estimated ownership levels in the Combined Company, immediately following the consummation of the Business Combination, based on the two levels of redemptions by the Public Stockholders and the following assumptions:
Pro Forma | Pro Forma | |||||||||||||||
Combined | Combined | |||||||||||||||
(Assuming current Redemptions) | (Assuming Maximum Redemptions) | |||||||||||||||
Ownership | Ownership | Ownership | Ownership | |||||||||||||
in shares | % | in shares | % | |||||||||||||
Achari Public Stockholders | 309,010 | 1.7 | % | - | 0.0 | % | ||||||||||
Achari Initial Stockholders | 468,750 | 2.6 | % | 468,750 | 2.6 | % | ||||||||||
Vaso Stockholders | 17,600,000 | 95.8 | % | 17,600,000 | 97.4 | % | ||||||||||
Pro forma Combined Company Common Stock at June 30, 2024 | 18,377,760 | 100.0 | % | 18,068,750 | 100.0 | % |
4
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
AS OF JUNE 30, 2024
(in thousands, except share and per share amounts)
Scenario 1 | Scenario 2 | |||||||||||||||||||||||||||
Current redemptions | Assuming Maximum Redemption | |||||||||||||||||||||||||||
June 30, 2024 | Transaction | Pro | Transaction | Pro | ||||||||||||||||||||||||
Achari | Vaso | Accounting | Forma | Accounting | Forma | |||||||||||||||||||||||
(Historical) | (Historical) | Adjustments | Note | Combined | Adjustments | Note | Combined | |||||||||||||||||||||
ASSETS | ||||||||||||||||||||||||||||
CURRENT ASSETS | ||||||||||||||||||||||||||||
Cash and cash equivalents | $ | 6 | $ | 25,652 | 3,564 | A,I | $ | 23,285 | (557 | ) | D,F | $ | 19,721 | |||||||||||||||
(3,500 | ) | B | (3,500 | ) | B | |||||||||||||||||||||||
(557 | ) | D,F | (1,880 | ) | E | |||||||||||||||||||||||
(1,880 | ) | E | ||||||||||||||||||||||||||
Short-term investments | - | - | - | - | ||||||||||||||||||||||||
Accounts and other receivables, net of an allowance for credit losses and commission adjustments of $9,615 | - | 7,213 | 7,213 | 7,213 | ||||||||||||||||||||||||
Receivables due from related parties | - | 1,098 | 1,098 | 1,098 | ||||||||||||||||||||||||
Inventories, net | - | 1,218 | 1,218 | 1,218 | ||||||||||||||||||||||||
Deferred commission expense | - | 3,316 | 3,316 | 3,316 | ||||||||||||||||||||||||
Prepaid expenses and other current assets | 19 | 2,392 | (343 | ) | M | 2,068 | (343 | ) | M | 2,068 | ||||||||||||||||||
Total current assets | 25 | 40,889 | (2,716 | ) | 38,198 | (6,280 | ) | 34,634 | ||||||||||||||||||||
Property and equipment, net of accumulated depreciation of $10,579 | - | 1,423 | 1,423 | 1,423 | ||||||||||||||||||||||||
Operating lease right of use assets | - | 2,328 | 2,328 | 2,328 | ||||||||||||||||||||||||
Goodwill | - | 15,556 | 15,556 | 15,556 | ||||||||||||||||||||||||
Cash held in Trust Account | 6,342 | - | (6,342 | ) | A,I | - | (6,342 | ) | I | - | ||||||||||||||||||
Intangibles, net | - | 1,489 | 1,489 | 1,489 | ||||||||||||||||||||||||
Other assets, net | - | 4,826 | 4,826 | 4,826 | ||||||||||||||||||||||||
Investment in EECP Global | - | 596 | 596 | 596 | ||||||||||||||||||||||||
Deferred tax assets, net | - | 4,956 | 4,956 | 4,956 | ||||||||||||||||||||||||
Total assets | $ | 6,367 | $ | 72,063 | $ | (9,057 | ) | $ | 69,372 | $ | (12,622 | ) | $ | 65,808 | ||||||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||||||||||
CURRENT LIABILITIES | ||||||||||||||||||||||||||||
Accounts payable | $ | - | $ | 2,953 | $ | 2,953 | $ | 2,953 | ||||||||||||||||||||
Accrued commissions | - | 937 | 937 | 937 | ||||||||||||||||||||||||
Accrued expenses and other liabilities | 4,158 | 5,080 | 687 | D | 10,291 | 687 | D | 10,291 | ||||||||||||||||||||
66 | H | 66 | H | |||||||||||||||||||||||||
300 | L | 300 | L | |||||||||||||||||||||||||
Finance lease liabilities - current | - | 62 | 62 | 62 | ||||||||||||||||||||||||
Operating lease liabilities - current | - | 1,074 | 1,074 | 1,074 | ||||||||||||||||||||||||
Sales tax payable | - | 704 | 704 | 704 | ||||||||||||||||||||||||
Income taxes payable | 23 | 90 | (23 | ) | D | 90 | (23 | ) | D | 90 | ||||||||||||||||||
Franchise tax payable | 3 | - | (3 | ) | D | - | (3 | ) | D | - | ||||||||||||||||||
Excise tax liability | 392 | - | (392 | ) | D | - | (392 | ) | D | - | ||||||||||||||||||
Deferred revenue - current portion | - | 15,924 | 15,924 | 15,924 | ||||||||||||||||||||||||
Notes payable - current portion | - | 9 | 9 | 9 | ||||||||||||||||||||||||
Note payable - related parties | 826 | - | (826 | ) | F | - | (826 | ) | F | - | ||||||||||||||||||
Notes payable - other | 343 | - | (343 | ) | D,M | - | (343 | ) | D,M | - | ||||||||||||||||||
Total current liabilities | 5,745 | 26,836 | (534 | ) | 32,047 | (534 | ) | 32,047 | ||||||||||||||||||||
LONG-TERM LIABILITIES | ||||||||||||||||||||||||||||
Notes payable, net of current portion | - | 1 | 1 | 1 | ||||||||||||||||||||||||
Finance lease liabilities, net of current portion | - | - | - | - | ||||||||||||||||||||||||
Operating lease liabilities, net of current portion | - | 1,254 | 1,254 | 1,254 | ||||||||||||||||||||||||
Deferred revenue, net of current portion | - | 15,776 | 15,776 | 15,776 | ||||||||||||||||||||||||
Derivative warrant liabilities | 207 | - | (178 | ) | K | 29 | (178 | ) | K | 29 | ||||||||||||||||||
Deferred underwriting fee payable | 3,500 | - | (3,500 | ) | B | - | (3,500 | ) | B | - | ||||||||||||||||||
Put option liability | - | - | 3,750 | J | 3,750 | 3,750 | J | 3,750 | ||||||||||||||||||||
Other long-term liabilities | - | 1,475 | 1,475 | 1,475 | ||||||||||||||||||||||||
Total long-term liabilities | 3,707 | 18,506 | 72 | 22,285 | 72 | 22,285 | ||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES | ||||||||||||||||||||||||||||
REDEEMABLE COMMON STOCK | ||||||||||||||||||||||||||||
Common stock subject to possible redemption: 550,941 shares at redemption value of $11.51 | 6,342 | (6,342 | ) | I | - | (6,342 | ) | I | - | |||||||||||||||||||
STOCKHOLDERS’ EQUITY | ||||||||||||||||||||||||||||
Preferred stock, $.0001 par value; 1,000,000 shares authorized; none issued or outstanding (Achari) | - | - | - | |||||||||||||||||||||||||
Preferred stock, $.01 par value; 1,000,000 shares authorized; none issued or outstanding (Vaso) | - | - | - | |||||||||||||||||||||||||
Common stock - Class A (Vaso Holding Corporation) $0.0001 par value; 100,000,000 authorized | 2 | G | 2 | 2 | G | 2 | ||||||||||||||||||||||
0 | I | - | I | |||||||||||||||||||||||||
0 | C | 0 | C | |||||||||||||||||||||||||
Common stock - Class B (Vaso Holding Corporation) $0.0001 par value; 10,000,000 authorized | - | - | - | - | ||||||||||||||||||||||||
Common stock, $.0001 par value; 100,000,000 shares authorized; 2,500,000 shares issued and outstanding (excluding 550,941 shares subject to possible redemption) (Achari) | 0 | (0 | ) | C | - | (0 | ) | C | - | |||||||||||||||||||
Common stock, $.001 par value; 250,000,000 shares authorized; 185,689,050 shares issued; 175,380,963 shares outstanding (Vaso) | 186 | 1 | H | - | 1 | H | - | |||||||||||||||||||||
(187 | ) | G | (187 | ) | G | |||||||||||||||||||||||
Additional paid-in capital | - | 64,011 | (3,750 | ) | J | 52,679 | (3,750 | ) | J | 49,115 | ||||||||||||||||||
95 | H | 95 | H | |||||||||||||||||||||||||
3,564 | I | - | I | |||||||||||||||||||||||||
185 | G | 185 | G | |||||||||||||||||||||||||
(9,427 | ) | C | (9,427 | ) | C | |||||||||||||||||||||||
(2,000 | ) | G | (2,000 | ) | G | |||||||||||||||||||||||
Accumulated deficit | (9,427 | ) | (35,050 | ) | (1,880 | ) | E | (37,214 | ) | (1,880 | ) | E | (37,214 | ) | ||||||||||||||
(162 | ) | H | (162 | ) | H | |||||||||||||||||||||||
9,427 | C | 9,427 | C | |||||||||||||||||||||||||
178 | K | 178 | K | |||||||||||||||||||||||||
(300 | ) | L | (300 | ) | L | |||||||||||||||||||||||
Accumulated other comprehensive loss | - | (426 | ) | (426 | ) | (426 | ) | |||||||||||||||||||||
Treasury stock, at cost, 10,308,087 shares | - | (2,000 | ) | 2,000 | G | - | 2,000 | G | - | |||||||||||||||||||
Total stockholders’ equity | (9,427 | ) | 26,721 | (2,254 | ) | 15,040 | (5,818 | ) | 11,476 | |||||||||||||||||||
$ | 6,367 | $ | 72,063 | $ | (9,057 | ) | $ | 69,372 | $ | (12,622 | ) | $ | 65,808 |
See accompanying notes to the unaudited pro forma condensed combined financial statements.
5
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
(in thousands, except share and per share amounts)
Scenario 1 | Scenario 2 | |||||||||||||||||||||||||||
For the six months ended | Current Redemptions | Assuming Maximum Redemption | ||||||||||||||||||||||||||
June 30, 2024 | Transaction | Pro | Transaction | Pro | ||||||||||||||||||||||||
Achari | Vaso | Accounting | Forma | Accounting | Forma | |||||||||||||||||||||||
(Historical) | (Historical) | Adjustments | Note | Combined | Adjustments | Note | Combined | |||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Managed IT systems and services | $ | - | $ | 20,743 | 20,743 | $ | 20,743 | |||||||||||||||||||||
Professional sales services | - | 17,237 | 17,237 | 17,237 | ||||||||||||||||||||||||
Equipment sales and services | - | 983 | 983 | 983 | ||||||||||||||||||||||||
Total revenues | - | 38,963 | - | 38,963 | - | 38,963 | ||||||||||||||||||||||
Cost of revenues | ||||||||||||||||||||||||||||
Cost of managed IT systems and services | - | 11,968 | 11,968 | 11,968 | ||||||||||||||||||||||||
Cost of professional sales services | - | 3,685 | 3,685 | 3,685 | ||||||||||||||||||||||||
Cost of equipment sales and services | - | 242 | 242 | 242 | ||||||||||||||||||||||||
Total cost of revenues | - | 15,895 | - | 15,895 | - | 15,895 | ||||||||||||||||||||||
Gross profit | - | 23,068 | - | 23,068 | - | 23,068 | ||||||||||||||||||||||
Operating expenses | ||||||||||||||||||||||||||||
Selling, general and administrative | 1,395 | 22,907 | 24,302 | 24,302 | ||||||||||||||||||||||||
Franchise Tax | 42 | 42 | 42 | |||||||||||||||||||||||||
Research and development | - | 396 | 396 | 396 | ||||||||||||||||||||||||
Business combination transaction costs | 238 | 238 | 238 | |||||||||||||||||||||||||
Total operating expenses | 1,437 | 23,541 | - | 24,978 | - | 24,978 | ||||||||||||||||||||||
Operating loss | (1,437 | ) | (473 | ) | - | (1,910 | ) | - | (1,910 | ) | ||||||||||||||||||
Other (expense) income | ||||||||||||||||||||||||||||
Interest and financing costs | - | (4 | ) | (4 | ) | (4 | ) | |||||||||||||||||||||
Interest and other income, net | - | 585 | 585 | 585 | ||||||||||||||||||||||||
Interest income on investments held in Trust Account | 160 | - | (160 | ) | AA | - | (160 | ) | AA | - | ||||||||||||||||||
Change in fair value of warrants | (99 | ) | - | 85 | BB | (14 | ) | 85 | BB | (14 | ) | |||||||||||||||||
Loss on disposal of fixed assets | - | (2 | ) | (2 | ) | (2 | ) | |||||||||||||||||||||
Total other income, net | 60 | 579 | (74 | ) | 565 | (74 | ) | 565 | ||||||||||||||||||||
Income (loss) before income taxes | (1,377 | ) | 106 | (74 | ) | (1,345 | ) | (74 | ) | (1,345 | ) | |||||||||||||||||
Income tax expense | (25 | ) | (124 | ) | 25 | AA | (124 | ) | 25 | AA | (124 | ) | ||||||||||||||||
Net loss | (1,401 | ) | (18 | ) | (50 | ) | (1,469 | ) | (50 | ) | (1,469 | ) | ||||||||||||||||
Net loss per common share | ||||||||||||||||||||||||||||
- basic and diluted | $ | (0.40 | ) | $ | (0.00 | ) | $ | 0.00 | $ | (0.08 | ) | $ | 0.16 | $ | (0.08 | ) | ||||||||||||
Weighted average common shares outstanding (Note 4) | ||||||||||||||||||||||||||||
- basic and diluted | 3,519 | 175,242 | (160,384 | ) | CC | 18,378 | (309 | ) | CC | 18,069 |
See accompanying notes to the unaudited pro forma condensed combined financial statements
6
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2023
(in thousands, except share and per share amounts)
Scenario 1 | Scenario 2 | |||||||||||||||||||||||||||
For the year ended | Current Redemptions | Assuming Maximum Redemption | ||||||||||||||||||||||||||
December 31, 2023 | Transaction | Pro | Transaction | Pro | ||||||||||||||||||||||||
Achari | Vaso | Accounting | Forma | Accounting | Forma | |||||||||||||||||||||||
(Historical) | (Historical) | Adjustments | Note | Combined | Adjustments | Note | Combined | |||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Managed IT systems and services | $ | 40,371 | 40,371 | $ | 40,371 | |||||||||||||||||||||||
Professional sales services | 37,820 | 37,820 | 37,820 | |||||||||||||||||||||||||
Equipment sales and services | 2,833 | 2,833 | 2,833 | |||||||||||||||||||||||||
Total revenues | - | 81,024 | - | 81,024 | - | 81,024 | ||||||||||||||||||||||
Cost of revenues | ||||||||||||||||||||||||||||
Cost of managed IT systems and services | 22,712 | 22,712 | 22,712 | |||||||||||||||||||||||||
Cost of professional sales services | 7,021 | 7,021 | 7,021 | |||||||||||||||||||||||||
Cost of equipment sales and services | 698 | 698 | 698 | |||||||||||||||||||||||||
Total cost of revenues | - | 30,431 | - | 30,431 | - | 30,431 | ||||||||||||||||||||||
Gross profit | - | 50,593 | - | 50,592 | - | 50,592 | ||||||||||||||||||||||
Operating expenses | ||||||||||||||||||||||||||||
Selling, general and administrative | 3,098 | 45,643 | 68 | DD | 50,989 | 68 | DD | 50,989 | ||||||||||||||||||||
300 | EE | 300 | EE | |||||||||||||||||||||||||
1,880 | FF | 1,880 | FF | |||||||||||||||||||||||||
Franchise Tax | 82 | - | 82 | 82 | ||||||||||||||||||||||||
Research and development | - | 755 | 94 | DD | 849 | 94 | DD | 849 | ||||||||||||||||||||
Total operating expenses | 3,180 | 46,398 | 2,342 | 51,920 | 2,342 | 51,920 | ||||||||||||||||||||||
Operating income (loss) | (3,180 | ) | 4,195 | (2,342 | ) | (1,327 | ) | (2,342 | ) | (1,327 | ) | |||||||||||||||||
Other (expense) income | ||||||||||||||||||||||||||||
Interest and financing costs | (50 | ) | (50 | ) | (50 | ) | ||||||||||||||||||||||
Interest and other income, net | 764 | 764 | 764 | |||||||||||||||||||||||||
Interest and dividend income on investments held in Trust Account | 429 | - | (429 | ) | AA | - | (429 | ) | AA | - | ||||||||||||||||||
Change in fair value of warrants | 249 | - | (214 | ) | BB | 35 | (214 | ) | BB | 35 | ||||||||||||||||||
Loss on disposal of fixed assets | (4 | ) | (4 | ) | (4 | ) | ||||||||||||||||||||||
Total other income, net | 678 | 710 | (643 | ) | 745 | (643 | ) | 745 | ||||||||||||||||||||
Income (loss) before income taxes | (2,502 | ) | 4,905 | (2,985 | ) | (582 | ) | (2,985 | ) | (582 | ) | |||||||||||||||||
Income tax benefit (expense) | (73 | ) | (100 | ) | 73 | AA | (100 | ) | 73 | AA | (100 | ) | ||||||||||||||||
Net income (loss) | (2,575 | ) | 4,805 | (2,912 | ) | (682 | ) | (2,912 | ) | (682 | ) | |||||||||||||||||
Net Income (loss) per common share | ||||||||||||||||||||||||||||
- basic | $ | (0.77 | ) | $ | 0.03 | $ | 0.02 | $ | (0.04 | ) | $ | 9.42 | $ | (0.04 | ) | |||||||||||||
- diluted | $ | (0.77 | ) | $ | 0.03 | $ | 0.02 | $ | (0.04 | ) | $ | 9.42 | $ | (0.04 | ) | |||||||||||||
Weighted average common shares outstanding (Note 4) | ||||||||||||||||||||||||||||
- basic | 3,337 | 174,441 | (159,400 | ) | CC | 18,378 | (309 | ) | CC | 18,069 | ||||||||||||||||||
- diluted | 3,337 | 175,541 | (160,500 | ) | CC | 18,378 | (309 | ) | CC | 18,069 |
See accompanying notes to the unaudited pro forma condensed combined financial statements
7
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Note 1 — Basis of Presentation
The Business Combination is expected to be accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Achari will be treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination will be treated as the equivalent of Vaso issuing shares for the net assets of Achari, accompanied by a recapitalization. The net assets of Achari will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination will be those of Vaso.
The unaudited pro forma condensed combined balance sheet as of June 30, 2024 gives pro forma effect to the Business Combination as if it had been consummated on June 30, 2024. The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2024 and for the year ended December 31, 2023 give pro forma effect to the Business Combination as if it had been consummated on January 1, 2023, the beginning of the earliest period presented in the unaudited pro forma condensed combined statements of operations. These periods are presented on the basis that Vaso is the acquirer for accounting purposes.
The unaudited pro forma condensed combined balance sheet as of June 30, 2024 has been prepared using, and should be read in conjunction with, the following:
● | Achari’s unaudited balance sheet as of June 30, 2024 and the related notes included in the Achari June 30 10-Q; and |
● | Vaso’s unaudited condensed consolidated balance sheet as of June 30, 2024 and the related notes included in the Vaso June 30 10-Q. |
The unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2024 has been prepared using, and should be read in conjunction with, the following:
● | Achari’s unaudited statement of operations for the six months ended June 30, 2024 and the related notes included in the Achari June 30 10-Q; and |
● | Vaso’s unaudited condensed consolidated statement of operations for the six months ended June 30, 2024 and the related notes included in the Vaso June 30 10-Q. |
The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2023 has been prepared using, and should be read in conjunction with, the following:
● | Achari’s audited statement of operations for the year ended December 31, 2023 and the related notes included in the Proxy Statement/Prospectus; and |
● | Vaso’s audited consolidated statement of operations for the year ended December 31, 2023 and the related notes included in the Proxy Statement/Prospectus. |
8
Management has made significant estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the information presented.
The pro forma adjustments reflecting the consummation of the Business Combination are based on information available as of the date hereof and certain assumptions and methodologies that management believes are reasonable under the circumstances. The unaudited condensed combined pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated. Therefore, the actual adjustments may materially differ from the pro forma adjustments. Management considers this basis of presentation to be reasonable under the circumstances.
The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of the post-combination company. They should be read in conjunction with the historical financial statements and notes thereto of Achari and Vaso included in the Achari June 30 10-Q, the Vaso June 30 10-Q and the Proxy Statement/Prospectus.
The unaudited pro forma condensed combined financial information included herein has been prepared using the assumptions below with respect to the potential redemption into cash of Achari common stock:
● | Assuming No Redemptions (Scenario 1): This presentation assumes that no Public Stockholders exercise their right to redeem their Public Shares (excluding the Redeemed Public Shares) for their pro rata share of the Trust Account, and thus, the full amount held in the Trust Account as of the Closing is available for the Business Combination; and |
● | Assuming Maximum Redemptions (Scenario 2): This presentation assumes that a maximum of 309,010 Public Shares issued and outstanding as of the Closing are redeemed at a redemption price of $11.51 per share as of June 30, 2024. |
The unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings, or cost savings that may be associated with the Business Combination.
The pro forma adjustments reflecting the consummation of the Business Combination are based on certain currently available information and certain assumptions and methodologies that Vaso believes are reasonable under the circumstances. The unaudited condensed pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments, and it is possible the difference may be material. Management believe that their assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Business Combination based on information available to management at this time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.
9
The unaudited pro forma condensed combined financial information does not reflect the deferred income tax effects of the pro forma adjustments as any change in the deferred tax balance would be offset by an increase in the valuation allowance. Upon Closing the Business Combination, it is likely that the Combined Company’s deferred tax assets, net of valuation allowance, will not change. The pro forma combined provision for income taxes does not necessarily reflect the amounts that would have resulted had the Combined Company filed consolidated income tax returns during the periods presented.
The pro forma basic and diluted income (loss) per share amounts presented in the unaudited pro forma condensed combined statements of operations are based upon the number of the Combined Company’s common shares outstanding, assuming the Business Combination occurred on January 1, 2023.
Note 2 — Accounting Policies
Upon consummation of the Business Combination, management will perform a comprehensive review of the two entities’ accounting policies. As a result of the review, management may identify differences between the accounting policies of the two entities which, when conformed, could have a material impact on the financial statements of the post-combination company. Based on its initial analysis, management did not identify any differences that would have a material impact on the unaudited pro forma condensed combined financial information. As a result, the unaudited pro forma condensed combined financial information does not assume any differences in accounting policies.
Note 3 — Adjustments to Unaudited Pro Forma Condensed Combined Financial Information
The unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the Business Combination and has been prepared for informational purposes only.
The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X Vaso has elected not to present Management’s Adjustments and will only be presenting Transaction Accounting Adjustments in the following unaudited pro forma condensed combined financial information.
Transaction Accounting Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet
The transaction accounting adjustments included in the unaudited pro forma condensed combined balance sheet as of June 30, 2024 are as follows:
(A) Reflects the reclassification of cash held in the Trust Account that becomes available for general use following the Business Combination;
(B) Reflects the payment of the $3,500,000 deferred underwriters’ discount that becomes due and payable upon the consummation of the Business Combination;
10
(C) Reflects the elimination of the historical accumulated deficit of Achari, the accounting acquiree, into Vaso’s additional paid-in capital upon the consummation of the Business Combination, and the conversion of 2,500,000 Founder Shares of Achari single class common stock into 750,000 shares of Vaso Holding Corp Class A common stock. Assumes Unpaid SPAC Expenses of $4.5 million, which would result in the forfeiture of 281,250 of the 750,000 Founder Shares to be held by Achari following the completion of the Business Combination pursuant to the terms of the Put Option Agreement and the Amended and Restated Vaso Working Capital Letter Agreement;
(D) Reflects the settlement of approximately $0.1 million of additional Achari unpaid costs related to the Business Combination. Approximately $5.1 million in Achari unpaid costs remaining in accrued expenses and other liabilities is responsibility of sponsor to settle at consummation of the Business Combination;
(E) Reflects the settlement of approximately $1.9 million of Vaso’s total estimated transaction costs related to the Business Combination and charge accumulated deficit as the costs are not attributable to raising equity for the transaction;
(F) Reflects the repayments of Achari’s working capital loans from the Sponsor of approximately $0.8 million;
(G) Reflects the recapitalization of Vaso through the issuance of 17,600,000 shares of Achari Class A common stock with $0.0001 par value to Vaso’s stockholders;
(H) Reflects accrual of stock compensation expenses of approximately $0.1 million in connection with the prior vesting of Vaso common stock granted under Vaso stock plans;
(I) Reflects the redemption of 241,931 shares following Achari’s special meeting held on July 16, 2024, valued at approximately $2.8 million, of the 550,941 Achari redeemable shares as of June 30, 2024. In Scenario 1, reflects the reclassification of 309,010 remaining shares of Achari common stock subject to possible redemption to permanent equity at $0.0001 par value. In Scenario 2, which assumes the same facts as described in Items A through H above, but reflects the assumption that all 309,010 shares of Achari common stock are redeemed for cash by Achari stockholders;
(J) Recognition of $6.0 million Achari put option liability applicable to 750,000 Founder Shares at $8.00 per share, less $2.25 million reduction for payment of excess unpaid SPAC expenses. The Put Option Agreement provides for reduction of up to $2.25 million in option liability for payment of Unpaid SPAC Expenses exceeding $2.25 million (total Unpaid SPAC Expenses cannot exceed $4.5 million);
(K) Reflects decrease in private placement warrant fair value as of June 30, 2024 due to reduction of warrants from 7,133,333 to 1,000,000 under the terms of the Business Combination; and
(L) Represents accrual of $0.3 million estimated Achari transaction costs to be incurred subsequent to June 30, 2024. Such costs are included in the $5.1 million unpaid costs described in Item D above.
(M) Elimination of $0.34 million Achari working capital loan payable to Vaso against Vaso loan receivable from Achari.
Transaction Accounting Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations
The transaction accounting adjustments included in the unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2024 and for the year ended December 31, 2023 are as follows:
(AA) Represents an adjustment to eliminate both the interest earned on investments held in Trust Account and the related income tax expense generated by such earned interest, as if the Business Combination had been consummated on January 1, 2023, the beginning of the earliest period presented;
11
(BB) Represents the removal of the change in fair value of the forfeited private placement warrants. 6,133,333 of the 7,133,333 private placement warrants will be forfeited under the terms of the Business Combination:
(CC) The calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the Business Combination had been consummated on January 1, 2023; in addition, as the Business Combination is being reflected as if it had occurred on this date, the calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the shares have been outstanding for the entire period presented (in Scenario 2, this calculation is retroactively adjusted to eliminate the 309,010 shares of Achari’s common stock redeemed for cash by Achari shareholders for the entire period);
(DD) Reflects the stock compensation expenses of approximately $0.2 million in connection with prior vestings and the issuance of 996,667 shares of Vaso common stock to various employees at the time of the consummation of the Business Combination (this adjustment is considered to be a one-time charge and is not expected to recur);
(EE) Reflects approximately $0.3 million in Achari transaction costs to be incurred subsequent to June 30, 2024 (this is a non-recurring item). These costs are included in the $5.1 million in Achari unpaid costs described in Note D; and
(FF) Reflects approximately $1.9 million in Vaso transaction costs to be incurred subsequent to June 30, 2024 (this is a non-recurring item).
Note 4 — Earnings per Share
Represents the earnings per share calculated using the historical weighted average shares outstanding, and the change in number of shares in connection with the Business Combination, assuming the shares were outstanding since the beginning of the earliest period presented in the unaudited pro forma condensed combined statements of operations. As the Business Combination and related transactions are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted earnings per share assumes that the shares issuable relating to the Business Combination have been outstanding for the entire period presented.
Basic and diluted earnings per share is computed by dividing pro forma net income by the weighted average number of the shares of Vaso Holding Corp Class A Common Stock outstanding during the periods.
The unaudited pro forma condensed combined earnings per share for the six months ended June 30, 2024 set out below has been prepared assuming (i) no redemptions and maximum redemptions and (ii) no Reverse Stock Split, a Reverse Stock Split with a 1.25-for-1 ratio, a Reverse Stock Split with a 1.5-for-1 ratio and a Reverse Stock Split with a 2-for-1 ratio:
For the Six Months Ended | ||||||||
June 30, 2024 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is no Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (1,468,820 | ) | $ | (1,468,820 | ) | ||
Weighted average shares outstanding - basic and diluted | 18,377,760 | 18,068,750 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.08 | ) | $ | (0.08 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 309,010 | - | ||||||
Achari Initial Stockholders | 468,750 | 468,750 | ||||||
Vaso Stockholders | 17,600,000 | 17,600,000 | ||||||
Total | 18,377,760 | 18,068,750 |
For the Six Months Ended | ||||||||
June 30, 2024 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is a 1.25-for-1 Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (1,468,820 | ) | $ | (1,468,820 | ) | ||
Weighted average shares outstanding - basic and diluted | 14,702,208 | 14,455,000 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.10 | ) | $ | (0.10 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 247,208 | - | ||||||
Achari Initial Stockholders | 375,000 | 375,000 | ||||||
Vaso Stockholders | 14,080,000 | 14,080,000 | ||||||
Total | 14,702,208 | 14,455,000 |
12
For the Six Months Ended | ||||||||
June 30, 2024 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is a 1.5-for-1 Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (1,468,820 | ) | $ | (1,468,820 | ) | ||
Weighted average shares outstanding - basic and diluted | 12,251,840 | 12,045,833 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.12 | ) | $ | (0.12 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 206,007 | - | ||||||
Achari Initial Stockholders | 312,500 | 312,500 | ||||||
Vaso Stockholders | 11,733,333 | 11,733,333 | ||||||
Total | 12,251,840 | 12,045,833 |
For the Six Months Ended | ||||||||
June 30, 2024 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is a 2-for-1 Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (1,468,820 | ) | $ | (1,468,820 | ) | ||
Weighted average shares outstanding - basic and diluted | 9,188,880 | 9,034,375 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.16 | ) | $ | (0.16 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 154,505 | - | ||||||
Achari Initial Stockholders | 234,375 | 234,375 | ||||||
Vaso Stockholders | 8,800,000 | 8,800,000 | ||||||
Total | 9,188,880 | 9,034,375 |
The unaudited pro forma condensed combined earnings per share for the year ended December 31, 2023 set out below has been prepared assuming (i) no redemptions and maximum redemptions and (ii) no Reverse Stock Split, a Reverse Stock Split with a 1.25-for-1 ratio, a Reverse Stock Split with a 1.5-for-1 ratio and a Reverse Stock Split with a 2-for-1 ratio:
For the Year Ended | ||||||||
December 31, 2023 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is no Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (681,924 | ) | $ | (681,924 | ) | ||
Weighted average shares outstanding - basic and diluted | 18,377,760 | 18,068,750 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.04 | ) | $ | (0.04 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 309,010 | - | ||||||
Achari Initial Stockholders | 468,750 | 468,750 | ||||||
Vaso Stockholders | 17,600,000 | 17,600,000 | ||||||
Total | 18,377,760 | 18,068,750 |
13
For the Year Ended | ||||||||
December 31, 2023 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is a 1.25-for-1 Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (681,924 | ) | $ | (681,924 | ) | ||
Weighted average shares outstanding - basic and diluted | 14,702,208 | 14,455,000 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.05 | ) | $ | (0.05 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 247,208 | - | ||||||
Achari Initial Stockholders | 375,000 | 375,000 | ||||||
Vaso Stockholders | 14,080,000 | 14,080,000 | ||||||
Total | 14,702,208 | 14,455,000 |
For the Year Ended | ||||||||
December 31, 2023 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is a 1.5-for-1 Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (681,924 | ) | $ | (681,924 | ) | ||
Weighted average shares outstanding - basic and diluted | 12,251,840 | 12,045,833 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.06 | ) | $ | (0.06 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 206,007 | - | ||||||
Achari Initial Stockholders | 312,500 | 312,500 | ||||||
Vaso Stockholders | 11,733,333 | 11,733,333 | ||||||
Total | 12,251,840 | 12,045,833 |
For the Year Ended | ||||||||
December 31, 2023 | ||||||||
Pro Forma | Pro Forma | |||||||
Combined | Combined | |||||||
If there is a 2-for-1 Reverse Stock Split | (Assuming Current Redemptions) | (Assuming Maximum Redemptions) | ||||||
Pro forma net loss attributable to the stockholders | $ | (681,924 | ) | $ | (681,924 | ) | ||
Weighted average shares outstanding - basic and diluted | 9,188,880 | 9,034,375 | ||||||
Pro forma net loss per share - basic and diluted | $ | (0.07 | ) | $ | (0.08 | ) | ||
Weighted average shares calculation, basic and diluted | ||||||||
Common Stock | ||||||||
Achari Public Stockholders | 154,505 | - | ||||||
Achari Initial Stockholders | 234,375 | 234,375 | ||||||
Vaso Stockholders | 8,800,000 | 8,800,000 | ||||||
Total | 9,188,880 | 9,034,375 |
14
1 Year Vaso (QX) Chart |
1 Month Vaso (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions